Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants

Ilia Z. Romero Méndez, Yi Shi, Harm HogenEsch, Stanley L. Hem

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

The degree of antigen adsorption by aluminum-containing adjuvants is considered an important characteristic of vaccines that is related to immunopotentiation by the adjuvant. This study examined immunopotentiation by aluminum phosphate adjuvant in three model vaccines in which the antigen was not adsorbed in the vaccine formulation nor when mixed in vitro with interstitial fluid. In the first model vaccine, aluminum phosphate adjuvant was pre-treated with 0.5 M KH2PO4 to minimize the adsorption of dephosphorylated alpha casein. The second model vaccine was composed of aluminum phosphate adjuvant and ovalbumin that was dephosphorylated by treatment with potato acid phosphatase. The third model vaccine consisted of aluminum phosphate adjuvant and lysozyme (LYS). In order to prevent adsorption of lysozyme, the aluminum phosphate adjuvant was pre-treated with fibrinogen, a protein present in interstitial fluid that binds strongly to aluminum phosphate adjuvant. Immunopotentiation was evaluated by measuring antibody production in mice. It was found that all three model vaccines induced antibody titers that were statistically higher than induced by a solution of antigen without adjuvant and similar to vaccines in which the antigens were adsorbed by aluminum phosphate adjuvant. Confocal microscopy experiments suggested that the antigens used in these experiments, even though not adsorbed to the aluminum phosphate adjuvant, were trapped in void spaces within the adjuvant aggregates, resulting in uptake of antigen by dendritic cells.

Original languageEnglish (US)
Pages (from-to)825-833
Number of pages9
JournalVaccine
Volume25
Issue number5
DOIs
StatePublished - Jan 15 2007
Externally publishedYes

Fingerprint

Aluminum
aluminum phosphate
adjuvants
aluminum
Vaccines
immune response
antigens
Antigens
vaccines
Adsorption
Extracellular Fluid
Muramidase
adsorption
extracellular fluids
lysozyme
Ovalbumin
Solanum tuberosum
Acid Phosphatase
Caseins
Confocal Microscopy

Keywords

  • Aluminum phosphate adjuvant
  • Antigen adsorption
  • Antigen trapping
  • Immunopotentiation

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants. / Romero Méndez, Ilia Z.; Shi, Yi; HogenEsch, Harm; Hem, Stanley L.

In: Vaccine, Vol. 25, No. 5, 15.01.2007, p. 825-833.

Research output: Contribution to journalArticle

Romero Méndez, Ilia Z. ; Shi, Yi ; HogenEsch, Harm ; Hem, Stanley L. / Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants. In: Vaccine. 2007 ; Vol. 25, No. 5. pp. 825-833.
@article{d9e585d1c43141f089c926b54d268370,
title = "Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants",
abstract = "The degree of antigen adsorption by aluminum-containing adjuvants is considered an important characteristic of vaccines that is related to immunopotentiation by the adjuvant. This study examined immunopotentiation by aluminum phosphate adjuvant in three model vaccines in which the antigen was not adsorbed in the vaccine formulation nor when mixed in vitro with interstitial fluid. In the first model vaccine, aluminum phosphate adjuvant was pre-treated with 0.5 M KH2PO4 to minimize the adsorption of dephosphorylated alpha casein. The second model vaccine was composed of aluminum phosphate adjuvant and ovalbumin that was dephosphorylated by treatment with potato acid phosphatase. The third model vaccine consisted of aluminum phosphate adjuvant and lysozyme (LYS). In order to prevent adsorption of lysozyme, the aluminum phosphate adjuvant was pre-treated with fibrinogen, a protein present in interstitial fluid that binds strongly to aluminum phosphate adjuvant. Immunopotentiation was evaluated by measuring antibody production in mice. It was found that all three model vaccines induced antibody titers that were statistically higher than induced by a solution of antigen without adjuvant and similar to vaccines in which the antigens were adsorbed by aluminum phosphate adjuvant. Confocal microscopy experiments suggested that the antigens used in these experiments, even though not adsorbed to the aluminum phosphate adjuvant, were trapped in void spaces within the adjuvant aggregates, resulting in uptake of antigen by dendritic cells.",
keywords = "Aluminum phosphate adjuvant, Antigen adsorption, Antigen trapping, Immunopotentiation",
author = "{Romero M{\'e}ndez}, {Ilia Z.} and Yi Shi and Harm HogenEsch and Hem, {Stanley L.}",
year = "2007",
month = "1",
day = "15",
doi = "10.1016/j.vaccine.2006.09.039",
language = "English (US)",
volume = "25",
pages = "825--833",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants

AU - Romero Méndez, Ilia Z.

AU - Shi, Yi

AU - HogenEsch, Harm

AU - Hem, Stanley L.

PY - 2007/1/15

Y1 - 2007/1/15

N2 - The degree of antigen adsorption by aluminum-containing adjuvants is considered an important characteristic of vaccines that is related to immunopotentiation by the adjuvant. This study examined immunopotentiation by aluminum phosphate adjuvant in three model vaccines in which the antigen was not adsorbed in the vaccine formulation nor when mixed in vitro with interstitial fluid. In the first model vaccine, aluminum phosphate adjuvant was pre-treated with 0.5 M KH2PO4 to minimize the adsorption of dephosphorylated alpha casein. The second model vaccine was composed of aluminum phosphate adjuvant and ovalbumin that was dephosphorylated by treatment with potato acid phosphatase. The third model vaccine consisted of aluminum phosphate adjuvant and lysozyme (LYS). In order to prevent adsorption of lysozyme, the aluminum phosphate adjuvant was pre-treated with fibrinogen, a protein present in interstitial fluid that binds strongly to aluminum phosphate adjuvant. Immunopotentiation was evaluated by measuring antibody production in mice. It was found that all three model vaccines induced antibody titers that were statistically higher than induced by a solution of antigen without adjuvant and similar to vaccines in which the antigens were adsorbed by aluminum phosphate adjuvant. Confocal microscopy experiments suggested that the antigens used in these experiments, even though not adsorbed to the aluminum phosphate adjuvant, were trapped in void spaces within the adjuvant aggregates, resulting in uptake of antigen by dendritic cells.

AB - The degree of antigen adsorption by aluminum-containing adjuvants is considered an important characteristic of vaccines that is related to immunopotentiation by the adjuvant. This study examined immunopotentiation by aluminum phosphate adjuvant in three model vaccines in which the antigen was not adsorbed in the vaccine formulation nor when mixed in vitro with interstitial fluid. In the first model vaccine, aluminum phosphate adjuvant was pre-treated with 0.5 M KH2PO4 to minimize the adsorption of dephosphorylated alpha casein. The second model vaccine was composed of aluminum phosphate adjuvant and ovalbumin that was dephosphorylated by treatment with potato acid phosphatase. The third model vaccine consisted of aluminum phosphate adjuvant and lysozyme (LYS). In order to prevent adsorption of lysozyme, the aluminum phosphate adjuvant was pre-treated with fibrinogen, a protein present in interstitial fluid that binds strongly to aluminum phosphate adjuvant. Immunopotentiation was evaluated by measuring antibody production in mice. It was found that all three model vaccines induced antibody titers that were statistically higher than induced by a solution of antigen without adjuvant and similar to vaccines in which the antigens were adsorbed by aluminum phosphate adjuvant. Confocal microscopy experiments suggested that the antigens used in these experiments, even though not adsorbed to the aluminum phosphate adjuvant, were trapped in void spaces within the adjuvant aggregates, resulting in uptake of antigen by dendritic cells.

KW - Aluminum phosphate adjuvant

KW - Antigen adsorption

KW - Antigen trapping

KW - Immunopotentiation

UR - http://www.scopus.com/inward/record.url?scp=33845187202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845187202&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2006.09.039

DO - 10.1016/j.vaccine.2006.09.039

M3 - Article

C2 - 17014935

AN - SCOPUS:33845187202

VL - 25

SP - 825

EP - 833

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 5

ER -